LauriceGeel Posted - 5 hours ago

$ABBV $ASML Reverse splits are often a bad sign. KSCP's move erodes my confidence in its strategic vision.

RunUpABag Posted - 7 hours ago

$NXGL 2025 is looking promising here 💰 - Profitability around the corner with enough cash runway into Profitability -NexDrape shown as CLEAR SUPERIOR over leading brands -PAIN DATA on their patches BEATS ANYTHING IN THE MARKET! This small company has already landed major distribution deals with $CTAS and $ABBV 🤝🏼

HostileCharts Posted - 1 day ago

$IXJ - iShares Global Healthcare ETF Finding support on the pullback, did not get oversold. Pretty clean r/r if you like buying the "NOT A TOP" trades. Top Holdings $LLY ~8% $UNH ~7% $NOVOB ~5% $JNJ ~5% $ABBV ~4%

DividendsAtValue Posted - 1 day ago

@Hammrrd Well I don't mess with spec pharma/biotech. I stick with solid pharma companies, $ABBV $PFE. They pay dividends and are pretty recession resistant. Only reason I got hurt in GILD is cause I bought to high...

DividendsAtValue Posted - 1 day ago

@Hammrrd Well about 50% my portfolio is in 🍎 and $ABBV (avg pp sh$77), 38 other stocks and 4 funds make up the rest. Always looking to eliminate weaker ones. But I have much opportunity loss. I hold losers for years if I have faith they'll come back. That's been the case for GILD (almost there) BABA and, as I mentioned, GEVO...

TalkMarkets Posted - 2 days ago

Johnson & Johnson Dividend Stock Analysis - Saturday, Oct. 12 $JNJ Also $BMY $LLY $ABBV https://talkmarkets.com/content/stocks--equities/johnson--johnson-dividend-stock-analysis-saturday-oct-12?post=465050

WeeklyTrader Posted - 2 days ago

Who's ready to bail on $ABBV? RSI: 50.56% 50-day MA: $193.95 200-day MA: $175.56

Oldpuck Posted - 3 days ago

$ABBV very weak. Going sideways until earnings

BTECHINV Posted - 4 days ago

$ALT $xbi Super drugs such as Rinvoq from $ABBV, and Keytruda from $MRK have shifted the Biotech and BP paradigm more towards a preference for "Pipeline in a Product" type drugs, rather than extensive pipelines of singles and doubles. GLP-1 Pemvidutide with a multi-indication label would be in keeping in my view with its seemingly extraordinarily broad and strong, inherent biological potential across Obesity + Cardiovascular + Liver Disease + CM, as well in keeping with the industry shift towards PiP. Its one of the reasons my inv. is here and not elsewhere in the GLP1 space. Pemvidutide is PiP writ large imo and can be an MOA leader in what may evolve to be one of the most important medical MOA's for Next-gen GLP-1's --> GCGR/GLP1 (GlucagonRA). Disclosure: Long Altimmune (Pemvidutide), not medical advice, not investment advice. ..

UltraInstinct Posted - 4 days ago

$ABBV trying to stay flat before the psychological $200 number hits.

IN0V8 Posted - 4 days ago

$ABBV Opportunity Truist Securities raises target price to $215 from $210

DividendsAtValue Posted - 4 days ago

$MNKD Added a bit here. Also long $ABBV $GILD $PFE

yus37 Posted - 4 days ago

$ORPOF $ABBV $XBI OSE Pharma has been flying under the radar while teaming up with AbbVie, Boehringer Ingelheim, Veloxis Pharmaceuticals, and CKD. These partnerships could lead to up to €2.1 billion in milestone payments, including €180 million already received.

IN0V8 Posted - 5 days ago

$ABBV UBS raises target price to $195 from $185

JuggernautRaider Posted - 5 days ago

Buy $TNXP <~ fight migraines Hold $pfe <~ little blue pills make babies Sell $GMAB <~ a company with an agist culture that $JNJ & $ABBV robbed blind!

dogDazeSummer Posted - 6 days ago

@MrCompassion thank goodness these conflicting guidelines are now deleted. They are/ and have been polar opposite of what the data show. While the politically corrupt NIH was busy approving shots that didn’t work - and continue to mask adverse side effects for $PFE $MRNA, they also circumvented Gohibic which would have saved lives. Sadly, Francis, Tony and Peter should all face accountability for knowingly lying about GOF and their collective roles in the biggest American tragedy & coverup since 1776. But our baby —InflaRx —success was not extinguished—-rather delayed -as they’ve been forced to explain the truth that Vilo is a miracle / life saving drug for Covid / ARDS/ PG and many others. Move over $ABBV there’s bout to be a new kid in town! When the dominos begin for fall later this year, a bold prediction of $5b isn’t unrealistic. Next up Euro.

DefenseMania Posted - 6 days ago

$ABBV $AMGN $BMY $LLY https://stocktwits.com/DefenseMania/message/588286389

WeeklyTrader Posted - 6 days ago

Riding the momentum wave! Buy a CALL on $ABBV at strike 195.0c!

anachartanalyst Posted - 6 days ago

https://anachart.com/market-update/october-8th-2024/ $META $TW $ABBV

DavidFloydTrader Posted - 1 week ago

$ABBV From a technical and options flow standpoint, I like longs in ABBV. The chart below highlights the entry, stop, and two upside price targets. I suggest taking 75% of your profit at Target #1. Please note that the P&L and position size are based on the current value of the Model Account, which is ~$32,000. NOTE: if you do not have access to the Swing Trade Service, it's available at no cost currently - simply sign up here: https://www.aspentrading.com/newsletter/

IN0V8 Posted - 1 week ago

$ABBV Opportunity TD Cowen raises target price to $225 from $195

Article_AI Posted - 1 week ago

$ABBV AbbVie sees Q3 adjusted EPS $2.88-$2.92, consensus $2.95 In a regulatory filing last night, AbbVie disclosed that reported GAAP earnings and adjusted non-GAAP earnings for the third quarter of 2024 are ex... https://www.stck.pro/news/ABBV/90676071/

Article_AI Posted - 1 week ago

$ABBV Jobs data surprise to upside: Morning Buzz Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.&nbsp; 1. STOCK NEWS: U.S. nonfarm payrolls rose 254,0... https://www.stck.pro/news/ABBV/90674626/

uberkauft Posted - 1 week ago

$ABBV AbbVie Inc. 14-Day RSI: 54.6 % from 52-Week Low: +43.9% % from 52-Week High: -2.3% Open Interest: 338,894 % Change: +1% Put/Call Ratio: 0.79 % Change: -0.6%

DividendsAtValue Posted - 1 week ago

@Motherloads You bullish GILD? I bought at Hep-C highs years ago. Do you have a thought on how high do you think GILD is going? Think it hits $90.50? How long do you think that will take? Appreciate your thoughts. Long $ABBV $GILD $MNKD $PFE T

D0C_H0LLIDAY Posted - 1 week ago

$ALT $XBI Just spent a few hours researching the top 20 or so biotechs by market cap. They almost all are researching weight loss drug(s) or have one approved. There are a few like $ABBV that have stated their disinterest in entering an already competitive market. I believe it will be P's MASH indication that ultimately puts it over the finish line, and ties it all together for a purchaser. It will do the following for whoever buys it: 1. Money will be made on P's MASH indication in a less crowded space 2. Competitors won't be able to use P for any of the several indications P will receive (namely, weight loss) 3. Money will be made on P as a maintenance/complimentary weight loss drug and/or primary weight loss drug for elderly populations even if it never becomes the most dominant weight loss drug in the market overall The bullish argument for P rests in its versatility. Holistic and multi-faceted.

FrnkTss Posted - 1 week ago

$ABBV 200 is coming if 20ema holds https://youtu.be/AfBFf68SXLc

DefenseMania Posted - 1 week ago

$ABBV something brewing with RCUS 💰💰💰💰 $PFE $LLY $GILD

theflynews Posted - 1 week ago

Jobs data surprise to upside: Morning Buzz - $ABBV - https://thefly.com/permalinks/entry.php/ABBVid3993542

DividendsAtValue Posted - 1 week ago

@jimmieB What can I say? I like drug stocks. Long $ABBV $GILD $PFE and Luckin, the caffeine of China 🇨🇳 ☕🇨🇳☕🇻🇳☕ https://youtu.be/F4MTHivAcyo?feature=shared